Get the Stockscreener App
1.63
1.88%
0.03
Regentis Biomaterials Ltd. Stock (RGNT) Forecast
The Regentis Biomaterials Ltd. (RGNT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.5496, representing a -4.93% decrease from the current price of $1.63. The highest analyst price target is $3.0294, and the lowest is $0.0698.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RGNT Price Target
Average 6.1757
(+278.88% Upside)
Is Regentis Biomaterials Ltd. (RGNT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 37.95 | Neutral |
| STOCH(9,6) | 4.9826 | Buy |
| STOCHRSI(14) | 14.44 | Buy |
| MACD(12,26) | -0.1032 | Sell |
| ADX(14) | 12.83 | Neutral |
| William %R | -94.55 | Buy |
| CCI(14) | -94.66 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.722
Sell
|
1.7189
Sell
|
| MA20 |
1.836
Sell
|
1.8037
Sell
|
| MA50 |
1.935
Sell
|
2.004
Sell
|
| MA100 |
2.4007
Sell
|
2.4507
Sell
|
| MA200 |
3.3512
Sell
|
3.4326
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, RGNT could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on RGNT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 37.95 indicates that RGNT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 4.9826 indicates that RGNT is oversold. This indicates that RGNT price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 14.44 indicates that RGNT is oversold. This suggests that RGNT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 12.83 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -94.66 indicates that RGNT is still oversold but not to an extreme extent.
Long-term RGNT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Regentis Biomaterials Ltd. financial reports and earnings history, Regentis Biomaterials Ltd. (RGNT) stock could reach $14.67 by 2030, $46.70 by 2040 and $56.38 by 2050. See the projected annual prices until 2050 of the Regentis Biomaterials Ltd. stock below:
- Regentis Biomaterials Ltd. (RGNT) is expected to reach an average price of $31.10 in 2035, with a high prediction of $33.18 and a low estimate of $31.31. This indicates an $1,808% rise from the last recorded price of $1.63.
- Regentis Biomaterials Ltd. (RGNT) stock is projected to chart a bullish course in 2040, with an average price target of $39.99, representing an $2,354% surge from its current level. The forecast ranges from a conservative $42.60 to a sky-high $46.70.
- Our analysts predict Regentis Biomaterials Ltd. (RGNT) to jump 2,838% by 2045, soaring from $48.15 to an average price of $47.89, potentially reaching $52.74. While $48.15 is the low estimate, the potential upside is significant.
- Regentis Biomaterials Ltd. (RGNT) stock is expected to climb by 2050, reaching an average of $47.98, a $2,844% jump from its current level. However, a wide range of estimates exists, with high and low targets of $56.38 and $48.02, respectively, highlighting the market's uncertainty.
Regentis Biomaterials Ltd. Stock (RGNT) Year by Year Forecast
Regentis Biomaterials Ltd. Stock (RGNT) Price Forecast for 2026
The predicted value for Regentis Biomaterials Ltd. (RGNT) in 2026 is set at an average of $7.7849. Estimates vary from a peak of $15.50 to a trough of $0.0698, indicating an +377.60% surge from the present price of $1.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $1.7794 | $0.0698 | $3.0294 | +9.16% |
| December, 2026 | $0.5715 | $0.2409 | $2.3493 | -64.94% |
Regentis Biomaterials Ltd. Stock (RGNT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Regentis Biomaterials Ltd. (RGNT) is $6.1757, with a high forecast of $12.34 and a low forecast of $0.0145. This indicates an +278.88% increase from the last price of $1.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.3264 | $1.0511 | $1.2215 | -18.62% |
| February, 2027 | $1.1319 | $1.2619 | $1.1417 | -30.56% |
| March, 2027 | $0.9224 | $1.0323 | $0.9124 | -43.41% |
| April, 2027 | $1.5828 | $1.6326 | $1.3726 | -2.90% |
| May, 2027 | $0.5467 | $0.2567 | $12.34 | -66.46% |
| June, 2027 | $0.6637 | $0.6066 | $1.7816 | -59.28% |
| July, 2027 | $0.1641 | $0.3141 | $0.3538 | -89.93% |
| August, 2027 | $0.00465 | $0.0145 | $0.1655 | -99.71% |
| September, 2027 | $0.1449 | $0.1252 | $0.7552 | -91.11% |
| October, 2027 | $5.2604 | $0.2348 | $4.0402 | +222.72% |
| November, 2027 | $3.5814 | $4.2912 | $4.0106 | +119.72% |
| December, 2027 | $5.6573 | $5.2919 | $5.1073 | +247.07% |
Regentis Biomaterials Ltd. Stock (RGNT) Price Forecast for 2028
In 2028, Regentis Biomaterials Ltd. (RGNT) is projected to reach an average price of $5.5544, with a high projection of $9.9784 and a low estimate of $1.1303. This indicates an +240.76% rise from the last price of $1.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.6941 | $5.8625 | $5.823 | +249.33% |
| February, 2028 | $5.0741 | $5.174 | $5.3635 | +211.30% |
| March, 2028 | $5.185 | $4.8849 | $4.7643 | +218.10% |
| April, 2028 | $5.3658 | $5.0656 | $4.9852 | +229.19% |
| May, 2028 | $1.7568 | $2.2868 | $9.1738 | +7.78% |
| June, 2028 | $3.3277 | $2.107 | $2.8877 | +104.15% |
| July, 2028 | $2.1287 | $2.1687 | $2.6781 | +30.59% |
| August, 2028 | $1.4695 | $1.5995 | $1.8789 | -9.85% |
| September, 2028 | $1.1003 | $1.1303 | $1.2897 | -32.49% |
| October, 2028 | $9.7612 | $9.8512 | $9.8821 | +498.85% |
| November, 2028 | $9.6225 | $9.5726 | $9.1816 | +490.34% |
| December, 2028 | $10.38 | $10.34 | $9.9784 | +536.82% |
Regentis Biomaterials Ltd. Stock (RGNT) Price Forecast for 2029
The 2029 price forecast for Regentis Biomaterials Ltd. Stock (RGNT) is $9.1188 on average, with a high prediction of $15.74 and a low estimate of $2.4955. This represents an +459.44% increase from the previous price of $1.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $9.9403 | $9.9953 | $10.43 | +509.83% |
| February, 2029 | $8.8265 | $9.1865 | $9.5506 | +441.50% |
| March, 2029 | $8.6893 | $8.6772 | $8.5978 | +433.08% |
| April, 2029 | $5.1993 | $7.8038 | $8.1287 | +218.98% |
| May, 2029 | $4.6205 | $4.9105 | $5.0098 | +183.47% |
| June, 2029 | $5.4418 | $5.6317 | $5.4215 | +233.85% |
| July, 2029 | $4.0133 | $4.0433 | $5.0321 | +146.22% |
| August, 2029 | $3.0946 | $3.1046 | $3.6436 | +89.85% |
| September, 2029 | $15.95 | $2.4955 | $15.74 | +878.53% |
| October, 2029 | $15.02 | $15.35 | $15.58 | +821.60% |
| November, 2029 | $15.37 | $14.80 | $14.15 | +843.17% |
| December, 2029 | $15.13 | $15.19 | $15.12 | +828.27% |
Regentis Biomaterials Ltd. Stock (RGNT) Price Forecast for 2030
Regentis Biomaterials Ltd. Stock (RGNT) is expected to reach an average price of $12.73 in 2030, with a high forecast of $21.60 and a low forecast of $3.8607. This signifies an +681.07% surge from the last price of $1.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $13.86 | $13.99 | $14.67 | +750.15% |
| February, 2030 | $12.62 | $12.68 | $13.32 | +674.18% |
| March, 2030 | $11.88 | $12.27 | $12.29 | +628.88% |
| April, 2030 | $8.3928 | $8.5422 | $11.55 | +414.90% |
| May, 2030 | $8.4745 | $7.7141 | $7.9931 | +419.91% |
| June, 2030 | $7.4161 | $7.6161 | $7.9553 | +354.98% |
| July, 2030 | $5.7282 | $5.7282 | $6.5865 | +251.42% |
| August, 2030 | $4.3299 | $4.3999 | $5.2986 | +165.64% |
| September, 2030 | $22.30 | $3.8607 | $21.60 | +1,268% |
| October, 2030 | $19.50 | $20.25 | $20.78 | +1,097% |
| November, 2030 | $20.42 | $20.03 | $19.59 | +1,152% |
| December, 2030 | $19.53 | $19.56 | $19.81 | +1,098% |
21.89%
12.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):